InvestorsHub Logo
Followers 155
Posts 45965
Boards Moderated 2
Alias Born 01/01/2005

Re: None

Thursday, 11/27/2014 12:28:44 PM

Thursday, November 27, 2014 12:28:44 PM

Post# of 2335871
#UPDATE ($ECGI MONSTER ALERT)> Event Cardio Group Acquires Worldwide Rights to Now Cardio(TM), Advanced Cardiac Monitoring

Device http://finance.yahoo.com/news/event-cardio-group-acquires-worldwide-153000725.html



#UPDATE $ECGI ALERT)> Projected Revevues for both "Breast Care Product & Cardiac Monitoring Device in 2015 are to be 45M$ APPROX


WATCH VIDEO>

Carol Fitzgerald, Life Medical Technologies: Moving the Needle to 100%
In case u guys missed it


-----------------------------------------------------------------

http://www.eventcardiogroup.com/ (below)

http://client.irwebkit.com/EventCardioGroup



Overview




Event Cardio Group Inc.

Event Cardio Group Inc. (ECGI) operates in the cardiac medical device innovation, patient monitoring and cardiac event prediction industry. The combined US cardiac equipment and services market in 2012 was estimated at $3.86 billion and is expected to grow to $4.19 billion in 2016. Globally, the cardiac monitoring market is anticipated at three to five times the US market value. The planning and forecasts for this business plan focus on the US market only.

The cardiac event monitoring industry has made few technological advances, thus negatively impacting patient persistence rates and diagnostic yields. Cumbersome leads and large monitors affect patients’ willingness to continue wearing the cardiac device for the entire prescribed duration of time recommended by health care professionals (HCPs).2 Diagnostic yields are mostly influenced by patients’ persistence to wear the current devices; as a result, the diagnostic yields available for interpretation are as low as 4% for holter monitors.3 There exists an opportunity to significantly improve diagnostic yields from the current 4% yield with holter monitors and the 62% documented yield levels with event recorders to greater than expected 90% yields with the Now Cardio device. The higher diagnostic yield will ensure more patients are identified sooner for their health risks, properly triaged and ultimately save many more lives.

Now Cardio is an innovative medical device designed by CONTEX International Technologies (Canada) Inc, a healthcare and aerospace high tech engineering firm. Now Cardio has many unique features which will differentiate this medical device from the competition with market-changing technology.







glta



"Everything i post is only my opinion"

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.